{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:02:39Z","timestamp":1779919359049,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["213"],"award-info":[{"award-number":["213"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jtct.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T07:05:32Z","timestamp":1633071932000},"page":"99.e1-99.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-8592","authenticated-orcid":false,"given":"M.Y. Eileen C.","family":"van der Stoep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-436X","authenticated-orcid":false,"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-253X","authenticated-orcid":false,"given":"Dirk Jan A.R.","family":"Moes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-1539","authenticated-orcid":false,"given":"Robbert G.M.","family":"Bredius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J.W.","family":"Smiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2755-9408","authenticated-orcid":false,"given":"Emilie P.","family":"Buddingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Mohseny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan","family":"Guchelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Zwaveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-2993","authenticated-orcid":false,"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.09.018_bib0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2012-04-423822","article-title":"Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan","volume":"120","author":"Bernardo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.09.018_bib0002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00277-014-2196-8","article-title":"Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia","volume":"94","author":"Boztug","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0003","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbmt.2014.08.020","article-title":"Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial","volume":"20","author":"Burroughs","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.09.018_bib0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.bjc.6690043","article-title":"DNA alkylation and interstrand cross-linking by treosulfan","volume":"79","author":"Hartley","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2021.09.018_bib0006","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.xphs.2017.03.018","article-title":"Kinetic and mechanistic study of the pH-dependent activation (epoxidation) of prodrug treosulfan including the reaction inhibition in a borate buffer","volume":"106","author":"Roma\u0144ski","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jtct.2021.09.018_bib0007","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0008","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1703612","article-title":"Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"McCune","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0009","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40262-019-00782-0","article-title":"Population pharmacokinetics of alemtuzumab (Campath) in pediatric hematopoietic cell transplantation: towards individualized dosing to improve outcome","volume":"58","author":"Admiraal","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtct.2021.09.018_bib0010","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0011","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.bbmt.2017.06.021","article-title":"Pharmacokinetics and model-based dosing to optimize fludarabine therapy in pediatric hematopoietic cell transplant recipients","volume":"23","author":"Ivaturi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106371","article-title":"Influence of anti-thymocyte globulin plasma levels on outcome parameters in stem cell transplanted children","volume":"83","author":"Vogelsang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0013","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00228-017-2344-x","article-title":"Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation","volume":"74","author":"Danielak","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0015","first-page":"326","article-title":"Development and validation of a high pressure liquid chromatography-UV method for the determination of treosulfan and its epoxy metabolites in human plasma and its application in pharmacokinetic studies","volume":"54","author":"Koyyalamudi","year":"2016","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.jtct.2021.09.018_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejps.2014.12.010","article-title":"Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT","volume":"68","author":"G\u0142\u00f3wka","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jtct.2021.09.018_bib0017","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FTD.0000000000000047","article-title":"Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"36","author":"Ten Brink","year":"2014","journal-title":"Ther Drug Monit"},{"issue":"suppl 2)","key":"10.1016\/j.jtct.2021.09.018_bib0018","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1038\/bmt.2008.287","article-title":"Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT","volume":"42","author":"G\u0142\u00f3wka","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cpt.1715","article-title":"Proposed therapeutic range of treosulfan in reduced toxicity pediatric allogeneic hematopoietic stem cell transplant conditioning: results from a prospective trial","volume":"108","author":"Chiesa","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtct.2021.09.018_bib0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bjh.14960","article-title":"High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study","volume":"179","author":"van der Stoep","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cpt.988","article-title":"Pharmacokinetics and pharmacodynamics of treosulfan in patients with thalassemia major undergoing allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Mohanan","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtct.2021.09.018_bib0022","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.09.018_bib0023","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/bcp.13995","article-title":"Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation","volume":"85","author":"van der Stoep","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0024","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on bioanalytical method validation. 2011.Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed June 1st 2021."},{"key":"10.1016\/j.jtct.2021.09.018_bib0025","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.018_bib0026","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jtct.2021.09.018_bib0027","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.09.018_bib0028","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/archdischild-2013-303720","article-title":"Understanding dosing: children are small adults, neonates are immature children","volume":"98","author":"Anderson","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jtct.2021.09.018_bib0029","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1078155218796905","article-title":"Thiotepa-induced cutaneous toxicity in pediatric patients: case report and implementation of preventive care guidelines","volume":"25","author":"Van Schandevyl","year":"2019","journal-title":"J Oncol Pharm Pract"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721012598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721012598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:07Z","timestamp":1763002867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721012598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2666636721012598"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.09.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}